BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 18618518)

  • 21. p53 Aberrations do not predict individual response to fludarabine in patients with B-cell chronic lymphocytic leukaemia in advanced stages Rai III/IV.
    Valgañón M; Giraldo P; Agirre X; Larráyoz MJ; Rubio-Martinez A; Rubio-Felix D; Calasanz MJ; Odero MD
    Br J Haematol; 2005 Apr; 129(1):53-9. PubMed ID: 15801955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telomerase expression in B-cell chronic lymphocytic leukemia predicts survival and delineates subgroups of patients with the same igVH mutation status and different outcome.
    Terrin L; Trentin L; Degan M; Corradini I; Bertorelle R; Carli P; Maschio N; Bo MD; Noventa F; Gattei V; Semenzato G; De Rossi A
    Leukemia; 2007 May; 21(5):965-72. PubMed ID: 17344921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
    Abousamra NK; El-Din MS; Azmy E
    Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toward a comprehensive prognostic scoring system in chronic lymphocytic leukemia based on a combination of genetic parameters.
    Haferlach C; Dicker F; Weiss T; Schnittger S; Beck C; Grote-Metke A; Oruzio D; Kern W; Haferlach T
    Genes Chromosomes Cancer; 2010 Sep; 49(9):851-9. PubMed ID: 20552631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IgVH gene mutation status and genomic imbalances in chronic lymphocytic leukaemia with increased prolymphocytes (CLL/PL).
    Balogh Z; Reiniger L; Deák L; Bödör C; Csomor J; Szepesi A; Gagyi E; Kopper L; Matolcsy A
    Hematol Oncol; 2007 Jun; 25(2):90-5. PubMed ID: 17410523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration.
    Laurenti L; Tarnani M; De Padua L; Efremov DG; Zini G; Garzia M; Piccirillo N; Chiusolo P; Sorà F; Innocenti I; Sica S; Leone G
    Ann Hematol; 2008 Nov; 87(11):891-8. PubMed ID: 18587576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic markers in chronic lymphocytic leukaemia.
    Hamblin TJ
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):455-68. PubMed ID: 17707833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia.
    Zenz T; Döhner H; Stilgenbauer S
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):439-53. PubMed ID: 17707832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgVH mutations in patients with chronic lymphocytic leukemia.
    Foà R
    Haematologica; 2005 Apr; 90(4):434-5. PubMed ID: 15820928
    [No Abstract]   [Full Text] [Related]  

  • 30. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
    Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM
    Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutated or non-mutated? Which database to choose when determining the IgVH hypermutation status in chronic lymphocytic leukemia?
    Peková S; Baran-Marszak F; Schwarz J; Matoska V
    Haematologica; 2006 Mar; 91(3):ELT01. PubMed ID: 16533734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors.
    Rossi D; Sozzi E; Puma A; De Paoli L; Rasi S; Spina V; Gozzetti A; Tassi M; Cencini E; Raspadori D; Pinto V; Bertoni F; Gattei V; Lauria F; Gaidano G; Forconi F
    Br J Haematol; 2009 Jun; 146(1):64-75. PubMed ID: 19438485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoimmune conditions and chronic infections in chronic lymphocytic leukemia patients at diagnosis are associated with unmutated IgVH genes.
    Vanura K; Le T; Esterbauer H; Späth F; Porpaczy E; Shehata M; Eigenberger K; Hauswirth A; Skrabs C; Krömer E; Schwarzinger I; Streubel B; Steininger C; Fonatsch C; Stilgenbauer S; Wagner O; Gaiger A; Jäger U
    Haematologica; 2008 Dec; 93(12):1912-6. PubMed ID: 18838479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia.
    Visco C; Moretta F; Falisi E; Facco M; Maura F; Novella E; Nichele I; Finotto S; Giaretta I; Ave E; Perbellini O; Guercini N; Scupoli MT; Trentin L; Trimarco V; Neri A; Semenzato G; Rodeghiero F; Pizzolo G; Ambrosetti A
    Am J Hematol; 2013 Apr; 88(4):277-82. PubMed ID: 23450508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma levels of basic fibroblast growth factor and vascular endothelial growth factor and their association with IgVH mutation status in patients with B-cell chronic lymphocytic leukemia.
    Smolej L; Andrys C; Peková S; Schwarz J; Belada D; Zák P
    Haematologica; 2006 Oct; 91(10):1432-3. PubMed ID: 17018398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia.
    van't Veer MB; Brooijmans AM; Langerak AW; Verhaaf B; Goudswaard CS; Graveland WJ; van Lom K; Valk PJ
    Haematologica; 2006 Jan; 91(1):56-63. PubMed ID: 16434371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical implications of ZAP-70 expressionin chronic lymphocytic leukemia.
    Bosch F; Muntañola A; Giné E; Carrió A; Villamor N; Moreno C; Crespo M; Montserrat E
    Cytometry B Clin Cytom; 2006 Jul; 70(4):214-7. PubMed ID: 16906580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk stratification in chronic lymphocytic leukemia.
    Seiler T; Döhner H; Stilgenbauer S
    Semin Oncol; 2006 Apr; 33(2):186-94. PubMed ID: 16616065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rel a is an independent biomarker of clinical outcome in chronic lymphocytic leukemia.
    Hewamana S; Lin TT; Rowntree C; Karunanithi K; Pratt G; Hills R; Fegan C; Brennan P; Pepper C
    J Clin Oncol; 2009 Feb; 27(5):763-9. PubMed ID: 19124804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia.
    Mauerer K; Zahrieh D; Gorgun G; Li A; Zhou J; Ansén S; Rassenti LZ; Gribben JG
    Br J Haematol; 2005 May; 129(4):499-510. PubMed ID: 15877732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.